Sermorelin Dosing Per Day: Clinical Guidelines

Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Sermorelin dosing typically begins at 0.15 mg to 0.5 mg per single subcutaneous injection, administered once daily in the evening. Clinical protocols vary based on individual baseline growth hormone status, age, body composition, and treatment objectives, requiring provider oversight throughout.

Understanding sermorelin dosing extends beyond a simple daily quantity—it requires recognizing how your unique physiology responds to growth hormone stimulation. PlexusDx emphasizes precision-based assessment to support more informed conversations between you and your healthcare provider about appropriate dosing adjustments.

Standard Sermorelin Dosing Ranges and Administration Timing

Most clinical protocols start sermorelin at 0.15 mg daily, administered via subcutaneous injection in the evening. Doses may be titrated upward in increments to 0.3 mg or 0.5 mg based on clinical response, IGF-1 levels, and tolerability assessments over weeks to months.

Evening injection timing aligns with the body's natural growth hormone secretion pattern, which peaks during early sleep. This scheduling may optimize the physiological signal that sermorelin sends to the anterior pituitary gland, supporting more natural hormone release patterns.

Clinical Factors That Influence Sermorelin Dose Decisions

Dosing adjustments depend on baseline growth hormone and IGF-1 levels, age, body composition, comorbidities, and concurrent medications. Providers use these markers to determine whether conservative starting doses or slightly higher initial doses are appropriate for each patient.

Clinical Factor	Impact on Dosing Decision
Baseline IGF-1 and GH Levels	Lower baseline values may allow higher starting doses; higher baseline may require more conservative approach
Age and Body Composition	Older adults or those with higher fat mass often benefit from lower starting doses with gradual titration
Kidney or Liver Function	Hepatic or renal impairment may necessitate dose reduction and more frequent monitoring
Concurrent Medications	Certain medications (estrogen, corticosteroids, diabetes agents) can affect GH secretion and influence optimal dosing
Treatment Goals	Goals focused on lean mass gain vs. general wellness may influence starting dose and titration pace

Sermorelin Dosing vs. Growth Hormone Replacement: Key Differences

Sermorelin is a growth hormone-releasing hormone analog that stimulates your own pituitary gland to produce and release GH. It differs fundamentally from direct growth hormone (GH) replacement, which introduces synthetic GH directly and requires different dosing strategies and monitoring.

Because sermorelin works via your body's natural regulatory mechanisms, dosing tends to be lower in absolute terms and adjustments are guided by circulating IGF-1 levels rather than direct GH measurement. This distinction is critical when reviewing dosing protocols from different treatment sources.

Safety Considerations, Monitoring, and Personalized Dose Optimization

Regular monitoring of IGF-1 levels, blood glucose, and clinical symptoms ensures sermorelin dosing remains appropriate and safe. Providers adjust doses if IGF-1 rises above optimal ranges, or if side effects such as joint aches, carpal tunnel symptoms, or fluid retention emerge.

Starting with conservative doses and titrating slowly allows your provider to identify your optimal dose—the amount that achieves your health goals while minimizing side effects. This individualized approach requires ongoing communication with your healthcare team and periodic reassessment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines variants in growth hormone-related pathways (such as genetic predispositions affecting metabolic capacity and tissue responsiveness) that may help provide context for how your physiology might respond to sermorelin dosing. This information should be interpreted with a qualified healthcare provider to inform initial dosing discussions.

Genetic predispositions in growth hormone signaling pathways do not predict exact sermorelin response, but they can support a more nuanced conversation about whether conservative or moderately higher starting doses may align better with your individual physiology. Your provider uses clinical biomarkers as the primary guide; genetic context complements that assessment.

Understanding your genetic landscape alongside baseline IGF-1, GH, and metabolic markers empowers you and your provider to make more informed initial dosing decisions and anticipate your potential response trajectory, supporting more personalized treatment from the start.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of sermorelin for adults?

Most protocols begin at 0.15 mg administered subcutaneously once daily in the evening. Doses are gradually adjusted upward based on IGF-1 levels, clinical response, and side effect profile over several weeks to months under provider supervision.

Can sermorelin dosing be adjusted if I don't see results after a few weeks?

Yes. Sermorelin often requires 4–8 weeks at a given dose before meaningful IGF-1 changes appear. Your provider may order IGF-1 labs and adjust the dose upward gradually if response is insufficient and tolerability is good.

Does age affect how much sermorelin I should take per day?

Age influences dosing because older adults often have lower baseline GH and IGF-1 levels and may experience different side effect profiles. Providers typically start older patients at lower doses and titrate more cautiously, monitoring closely for joint symptoms or carpal tunnel effects.

What is the maximum safe daily dose of sermorelin?

Clinical studies typically use doses up to 0.5 mg daily; some protocols explore higher amounts under close monitoring. Maximum safe dosing depends on individual factors and should always be determined by a qualified provider, not self-adjusted.

How does the Precision Peptide Genetic Test relate to sermorelin dosing decisions?

The test reveals genetic predispositions in growth hormone and metabolic pathways that may help contextualize your baseline physiology. This information can support a more informed initial dosing conversation with your provider, though clinical biomarkers (IGF-1, GH levels) remain the primary guide for dose adjustments.

How Much Sermorelin Per Day: Dosing Framework and Clinical Considerations

Sermorelin dosing typically ranges from 0.15 to 0.5 mg per injection, administered once daily in the evening. Actual dosing depends on individual health status, baseline growth hormone levels, treatment goals, and provider assessment.